SREBF1 and malignant colon neoplasm: The SREBP1/2 pathway was the only one that showed similar trends in the tumors and the MBTPS1 KO cells, results which are in agreement with earlier findings which showed that downregulation of SREBPs inhibits tumor growth in colon cancer (20).